1. Home
  2. ETON vs FEIM Comparison

ETON vs FEIM Comparison

Compare ETON & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • FEIM
  • Stock Information
  • Founded
  • ETON 2017
  • FEIM 1961
  • Country
  • ETON United States
  • FEIM United States
  • Employees
  • ETON N/A
  • FEIM N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • FEIM Electrical Products
  • Sector
  • ETON Health Care
  • FEIM Industrials
  • Exchange
  • ETON Nasdaq
  • FEIM Nasdaq
  • Market Cap
  • ETON 199.5M
  • FEIM 119.5M
  • IPO Year
  • ETON 2018
  • FEIM N/A
  • Fundamental
  • Price
  • ETON $8.82
  • FEIM $12.80
  • Analyst Decision
  • ETON Strong Buy
  • FEIM
  • Analyst Count
  • ETON 3
  • FEIM 0
  • Target Price
  • ETON $12.00
  • FEIM N/A
  • AVG Volume (30 Days)
  • ETON 214.1K
  • FEIM 19.0K
  • Earning Date
  • ETON 11-11-2024
  • FEIM 12-10-2024
  • Dividend Yield
  • ETON N/A
  • FEIM 7.98%
  • EPS Growth
  • ETON N/A
  • FEIM N/A
  • EPS
  • ETON N/A
  • FEIM 0.62
  • Revenue
  • ETON $31,381,000.00
  • FEIM $57,943,000.00
  • Revenue This Year
  • ETON $19.61
  • FEIM N/A
  • Revenue Next Year
  • ETON $35.39
  • FEIM N/A
  • P/E Ratio
  • ETON N/A
  • FEIM $20.24
  • Revenue Growth
  • ETON 8.14
  • FEIM 28.82
  • 52 Week Low
  • ETON $3.03
  • FEIM $7.20
  • 52 Week High
  • ETON $8.66
  • FEIM $14.50
  • Technical
  • Relative Strength Index (RSI)
  • ETON 76.07
  • FEIM 52.77
  • Support Level
  • ETON $7.58
  • FEIM $12.17
  • Resistance Level
  • ETON $8.66
  • FEIM $12.72
  • Average True Range (ATR)
  • ETON 0.42
  • FEIM 0.37
  • MACD
  • ETON -0.07
  • FEIM 0.01
  • Stochastic Oscillator
  • ETON 91.49
  • FEIM 45.37

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

Share on Social Networks: